Clinical Trial

Epidemiological and Clinical Characteristics of Mpox Outbreak in Equateur, the DR Congo (Part1)

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated July 9, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to characterize the clinical features of the 2024 mpox outbreak in Equateur Province of DRC and to identify associated risk factors. The main question it aims to answer is: * What are the clinical features of the 2024 mpox outbreak in Equateur Province of DRC? * What are the associated risk factors of the 2024 mpox outbreak? Participants which has mpox like symptoms will answer mpox investigations related questions and be collected skin lesions and whole blood samples.
Trial Details
NCT Number NCT07055867
Lead Sponsor Osaka Metropolitan University
Collaborators: Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Conditions Mpox (Monkeypox)
Enrollment 122 participants
Start Date 2024-08-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-09